TBG Diagnostics Ltd (TBG Diagnostics), formerly Progen Pharmaceuticals Ltd, is a molecular diagnostics company that develops, manufactures and markets molecular diagnostics kits, instruments and services. The company’s major products include COVID-19 testing kits, nucleic acid extraction kits, HLA SBT typing kits, HPA genotyping kits, an automated pipetting system, and gel electrophoresis. It serves clinical laboratories of hospitals and independent reference labs, blood centers, and bone marrow registry labs worldwide. TBG Diagnostics has research and development (R&D) facilities in the US, Taiwan and China and a manufacturing facility in Xiamen, China. The company has collaboration and product licensing agreements with various pharmaceutical companies and others. TBG Diagnostics is headquartered in Melbourne, Victoria, Australia.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company TBG Diagnostics Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- TBG Diagnostics Ltd Company Overview
- TBG Diagnostics Ltd Company Snapshot
- TBG Diagnostics Ltd Pipeline Products and Ongoing Clinical Trials Overview
- TBG Diagnostics Ltd - Pipeline Analysis Overview
- Business Description
- TBG Diagnostics Ltd - Key Facts
- TBG Diagnostics Ltd - Major Products and Services
- TBG Diagnostics Ltd Pipeline Products by Development Stage
- TBG Diagnostics Ltd Pipeline Products Overview
- Diagnostic Assay - GBS
- Diagnostic Assay - GBS Product Overview
- Diagnostic Assay - HIV
- Diagnostic Assay - HIV Product Overview
- Diagnostic Assay - Hospital Acquired Infections
- Diagnostic Assay - Hospital Acquired Infections Product Overview
- Diagnostic Assay - HPV
- Diagnostic Assay - HPV Product Overview
- Diagnostic Assay - Quant. HBV
- Diagnostic Assay - Quant. HBV Product Overview
- Diagnostic Assay - Quant. HCV
- Diagnostic Assay - Quant. HCV Product Overview
- Diagnostic Assay - STDs
- Diagnostic Assay - STDs Product Overview
- Diagnostic Assay - Transplantation
- Diagnostic Assay - Transplantation Product Overview
- Diagnostic Blood Detection Kit - HCV
- Diagnostic Blood Detection Kit - HCV Product Overview
- Diagnostic Test - Grave's Disease
- Diagnostic Test - Grave's Disease Product Overview
- ExProbe ABDRDQ
- ExProbe ABDRDQ Product Overview
- ExProbe ABHPA
- ExProbe ABHPA Product Overview
- ExProbe B27 Kit
- ExProbe B27 Kit Product Overview
- Integrated Automated Clinical System
- Integrated Automated Clinical System Product Overview
- SARS-CoV-2 IgG/IgM Rapid Test Kit
- SARS-CoV-2 IgG/IgM Rapid Test Kit Product Overview
- TBG Kit - Autoimmune Disease
- TBG Kit - Autoimmune Disease Product Overview
- TBG Kit - Blood Safety
- TBG Kit - Blood Safety Product Overview
- TBG Kit - Hereditary Genetic Disease
- TBG Kit - Hereditary Genetic Disease Product Overview
- TBG Kit - Infectious Disease
- TBG Kit - Infectious Disease Product Overview
- TBG Kit - Oncology
- TBG Kit - Oncology Product Overview
- TBG Kit - Transplantation
- TBG Kit - Transplantation Product Overview
- TBG Diagnostics Ltd - Key Competitors
- TBG Diagnostics Ltd - Key Employees
- TBG Diagnostics Ltd - Key Employee Biographies
- TBG Diagnostics Ltd - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- TBG Diagnostics Ltd, Recent Developments
- May 28, 2019: TBG Diagnostics: Board changes
- Feb 01, 2019: TBG Diagnostics appoints Willy M. Hsu as Chief Operating Officer
- Apr 26, 2018: TBG Diagnostics: Director Appointment /Resignation
- Oct 23, 2017: TBG Biotechnology First to Receive China FDA Approval for High Resolution HLA Genotyping for Hematopietic Cell Transplantation
- Aug 08, 2017: TBG ExProbe Real Time PCR Based Typing Kit receives Taiwan FDA approval and CE Mark, immediately opens markets
- Jul 19, 2017: TBG Diagnostics Received ASHI accreditation for Xiamen facility
- Nov 17, 2015: TBG Biotechnology (Xiamen) has obtained ISO13485 certification
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- TBG Diagnostics Ltd Pipeline Products and Ongoing Clinical Trials Overview
- TBG Diagnostics Ltd Pipeline Products by Equipment Type
- TBG Diagnostics Ltd Pipeline Products by Indication
- TBG Diagnostics Ltd, Key Facts
- TBG Diagnostics Ltd, Major Products and Services
- TBG Diagnostics Ltd Number of Pipeline Products by Development Stage
- TBG Diagnostics Ltd Pipeline Products Summary by Development Stage
- Diagnostic Assay - GBS - Product Status
- Diagnostic Assay - GBS - Product Description
- Diagnostic Assay - HIV - Product Status
- Diagnostic Assay - HIV - Product Description
- Diagnostic Assay - Hospital Acquired Infections - Product Status
- Diagnostic Assay - Hospital Acquired Infections - Product Description
- Diagnostic Assay - HPV - Product Status
- Diagnostic Assay - HPV - Product Description
- Diagnostic Assay - Quant. HBV - Product Status
- Diagnostic Assay - Quant. HBV - Product Description
- Diagnostic Assay - Quant. HCV - Product Status
- Diagnostic Assay - Quant. HCV - Product Description
- Diagnostic Assay - STDs - Product Status
- Diagnostic Assay - STDs - Product Description
- Diagnostic Assay - Transplantation - Product Status
- Diagnostic Assay - Transplantation - Product Description
- Diagnostic Blood Detection Kit - HCV - Product Status
- Diagnostic Blood Detection Kit - HCV - Product Description
- Diagnostic Test - Grave's Disease - Product Status
- Diagnostic Test - Grave's Disease - Product Description
- ExProbe ABDRDQ - Product Status
- ExProbe ABDRDQ - Product Description
- ExProbe ABHPA - Product Status
- ExProbe ABHPA - Product Description
- ExProbe B27 Kit - Product Status
- ExProbe B27 Kit - Product Description
- Integrated Automated Clinical System - Product Status
- Integrated Automated Clinical System - Product Description
- SARS-CoV-2 IgG/IgM Rapid Test Kit - Product Status
- SARS-CoV-2 IgG/IgM Rapid Test Kit - Product Description
- TBG Kit - Autoimmune Disease - Product Status
- TBG Kit - Autoimmune Disease - Product Description
- TBG Kit - Blood Safety - Product Status
- TBG Kit - Blood Safety - Product Description
- TBG Kit - Hereditary Genetic Disease - Product Status
- TBG Kit - Hereditary Genetic Disease - Product Description
- TBG Kit - Infectious Disease - Product Status
- TBG Kit - Infectious Disease - Product Description
- TBG Kit - Oncology - Product Status
- TBG Kit - Oncology - Product Description
- TBG Kit - Transplantation - Product Status
- TBG Kit - Transplantation - Product Description
- TBG Diagnostics Ltd, Key Employees
- TBG Diagnostics Ltd, Key Employee Biographies
- TBG Diagnostics Ltd, Subsidiaries
- Glossary
- TBG Diagnostics Ltd Pipeline Products by Equipment Type
- TBG Diagnostics Ltd Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Accelerate Diagnostics Inc
- Becton Dickinson and Co
- Luminex Corp
- Immucor Inc
- Bruker Corp
